Agnieszka Szwajda

发表

Network pharmacology modeling identifies synergistic Aurora B and ZAK interaction in triple-negative breast cancer

Sanna Timonen, Krister Wennerberg, Tero Aittokallio, 2019, npj Systems Biology and Applications.

Drafting the CLN3 protein interactome in SH-SY5Y human neuroblastoma cells: a label-free quantitative proteomics approach.

A. Gingras, M. Lalowski, M. Baumann, 2013, Journal of proteome research.

Bioinformatic identification of disease driver networks using functional profiling data

Agnieszka Szwajda, 2018 .

Age-of-onset information helps identify 76 genetic variants associated with allergic disease

Manuel A. R. Ferreira, J. Witte, G. Abecasis, 2020, PLoS genetics.

Frailty trajectories in three longitudinal studies of aging: Is the level or the rate of change more predictive of mortality?

S. Hägg, N. Pedersen, I. Karlsson, 2021, Age and ageing.

Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.

Krister Wennerberg, Tero Aittokallio, Laura Turunen, 2013, Cancer discovery.

Quantitative analysis of PPT 1 interactome in human neuroblastoma cells

A. Gingras, M. Lalowski, M. Baumann, 2016 .

Genetic Architectures of Childhood- and Adult-Onset Asthma Are Partly Distinct.

Manuel A. R. Ferreira, D. Hinds, J. Vonk, 2019, American journal of human genetics.

Naturally Occurring Human Phosphorylcholine Antibodies Are Predominantly Products of Affinity-Matured B Cells in the Adult

J. Stéen, K. Amara, V. Malmström, 2014, The Journal of Immunology.

B Cells in the Adult Predominantly Products of Affinity-Matured Phosphorylcholine Antibodies Are Naturally Occurring Human

J. Stéen, K. Amara, V. Malmström, 2014 .

Taking the LEAP: study protocol for a randomized, multicentre, naturalistic, efficacy trial of the compuLsive Exercise Activity theraPy (LEAP) - a cognitive behavioral program specifically targeting compulsive exercise in patients with eating disorders

C. Meyer, Agnieszka Szwajda, E. Monell, 2021, BMC Psychiatry.

Systematic Mapping of Kinase Addiction Combinations in Breast Cancer Cells by Integrating Drug Sensitivity and Selectivity Profiles.

Krister Wennerberg, Tero Aittokallio, Laura Turunen, 2015, Chemistry & biology.

From drug response profiling to target addiction scoring in cancer cell models

Krister Wennerberg, Tero Aittokallio, Agnieszka Szwajda, 2015, Disease Models & Mechanisms.

Global Analysis of S-nitrosylation Sites in the Wild Type (APP) Transgenic Mouse Brain-Clues for Synaptic Pathology *

M. Lalowski, A. Wysłouch-Cieszyńska, M. Dadlez, 2014, Molecular & Cellular Proteomics.

Making Sense of Large-Scale Kinase Inhibitor Bioactivity Data Sets: A Comparative and Integrative Analysis

Tao Xu, Krister Wennerberg, Tero Aittokallio, 2014, J. Chem. Inf. Model..

Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies

Krister Wennerberg, Tero Aittokallio, Agnieszka Szwajda, 2014, Scientific Reports.

Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells

Krister Wennerberg, Tero Aittokallio, Agnieszka Szwajda, 2016, Molecular Cancer.

Rare variant analysis in eczema identifies exonic variants in DUSP1, NOTCH4 and SLC9A4

Catherine L. Worth, M. Jarvelin, C. Gieger, 2021, Nature Communications.

Proteomic analysis of the palmitoyl protein thioesterase 1 interactome in SH-SY5Y human neuroblastoma cells.

A. Gingras, M. Lalowski, M. Baumann, 2015, Journal of proteomics.

Quantitative analysis of PPT1 interactome in human neuroblastoma cells

A. Gingras, M. Lalowski, M. Baumann, 2015, Data in brief.

Target Inhibition Networks: Predicting Selective Combinations of Druggable Targets to Block Cancer Survival Pathways

Tao Xu, Krister Wennerberg, Tero Aittokallio, 2013, PLoS Comput. Biol..

Toward more realistic drug^target interaction predictions

Tapio Pahikkala, Antti Airola, Tero Aittokallio, 2014 .

Integrated Human Evaluation of the Lysophosphatidic Acid Pathway as a Novel Therapeutic Target in Atherosclerosis

V. Emilsson, B. Nielsen, P. Eriksson, 2018, Molecular Therapy: Methods & Clinical Development.

Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells.

Yuba Raj Pokharel, K. Cole, T. Aittokallio, 2013, Cancer research.

Therapeutics , Targets , and Chemical Biology Chk 1 TargetingReactivates PP 2 ATumor Suppressor Activity in Cancer Cells

Yuba Raj Pokharel, K. Cole, T. Aittokallio, 2013 .

Network pharmacology modeling identifies synergistic Aurora B and ZAK interaction in triple-negative breast cancer

T. Aittokallio, J. Saez-Rodriguez, S. Timonen, 2019, npj Systems Biology and Applications.

Network pharmacology modeling identifies synergistic Aurora B and ZAK interaction in triple-negative breast cancer

T. Aittokallio, J. Saez-Rodriguez, S. Timonen, 2019, npj Systems Biology and Applications.

Relevance Rank Platform (RRP) for Functional Filtering of High Content Protein–Protein Interaction Data*

Krister Wennerberg, Tero Aittokallio, Agnieszka Szwajda, 2015, Molecular & Cellular Proteomics.

European and multi-ancestry genome-wide association meta-analysis of atopic dermatitis highlights importance of systemic immune regulation

Hongmei, Laurent F. Thomas, M. Jarvelin, 2022, medRxiv.

Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.

T. Aittokallio, S. Mustjoki, O. Kallioniemi, 2013, Cancer discovery.

Toward more realistic drug–target interaction predictions

T. Aittokallio, T. Pahikkala, A. Airola, 2014, Briefings Bioinform..